Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorZagazig University
About this trial
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Eligibility criteria
Qualifiers
Patients scheduled to undergo mitral valve surgery by cardiopulmonary bypass with estimated mean pulmonary artery pressure =>55 estimated by using preoperative Doppler echocardiography
Disqualifiers
None
Trial design
Treatments tested in this trial
- Milrinone inhalation
- Milrinone infusion
Treatment groups
38 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov